Decouvor collaborates with multiple globally licensed biological laboratories to develop candidate therapeutics for medical responses to bioterrorism, including those targeting Bacillus anthracis and Yersinia pestis. We offer biosafety level BSL-2 (P2) and BSL-3 (P3) laboratory services.
In collaboration with multiple globally certified laboratories with biosafety licenses, we conduct preclinical studies in BSL-2 (P2) or BSL-3 (P3) laboratories. Our services include developing experimental protocols, optimizing candidate drug formulations, adhering to regulatory requirements, actively engaging with regulatory authorities, and providing biosafety data that meets regulatory standards.
In collaboration with multiple globally certified laboratories with biosafety licenses, we conduct in vitro studies in BSL-2 (P2) or BSL-3 (P3) laboratories. Our assays include ELISA, biomarker cytokine expression analysis, immunogenicity testing, qPCR and RT-qPCR assays, immunological assessments, and inhalation toxicology testing.